159 related articles for article (PubMed ID: 1688014)
1. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States.
Wartofsky L; Glinoer D; Solomon B; Nagataki S; Lagasse R; Nagayama Y; Izumi M
Thyroid; 1991; 1(2):129-35. PubMed ID: 1688014
[TBL] [Abstract][Full Text] [Related]
2. Differences and similarities in the treatment of diffuse goiter in Europe and the United States.
Wartofsky L; Glinoer D; Solomon B; Lagasse R
Exp Clin Endocrinol; 1991 May; 97(2-3):243-51. PubMed ID: 1717298
[TBL] [Abstract][Full Text] [Related]
3. International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China.
Tominaga T; Yokoyama N; Nagataki S; Cho BY; Koh CS; Chen JL; Shi Y
Thyroid; 1997 Apr; 7(2):217-20. PubMed ID: 9133688
[TBL] [Abstract][Full Text] [Related]
4. A 2013 European survey of clinical practice patterns in the management of Graves' disease.
Bartalena L; Burch HB; Burman KD; Kahaly GJ
Clin Endocrinol (Oxf); 2016 Jan; 84(1):115-20. PubMed ID: 25581877
[TBL] [Abstract][Full Text] [Related]
5. The management of hyperthyroidism due to Graves' disease in Japan in 1988. The Japan Thyroid Association.
Nagayama Y; Izumi M; Nagataki S
Endocrinol Jpn; 1989 Apr; 36(2):299-314. PubMed ID: 2476301
[TBL] [Abstract][Full Text] [Related]
6. The management of hyperthyroidism due to Graves' disease in the former USSR in 1991: results of a survey.
Gerasimov G; Judenitch O; Zdanova E; Jurieva N; Korostishevskaja I; Mushinskaja K; Dedov I; Glinoer D
J Endocrinol Invest; 1992; 15(7):513-7. PubMed ID: 1360021
[TBL] [Abstract][Full Text] [Related]
7. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
Buerklin EM; Schimmel M; Utiger RD
J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
[TBL] [Abstract][Full Text] [Related]
8. A 2011 survey of clinical practice patterns in the management of Graves' disease.
Burch HB; Burman KD; Cooper DS
J Clin Endocrinol Metab; 2012 Dec; 97(12):4549-58. PubMed ID: 23043191
[TBL] [Abstract][Full Text] [Related]
9. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
10. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
11. Current trends in the management of Graves' disease.
Solomon B; Glinoer D; Lagasse R; Wartofsky L
J Clin Endocrinol Metab; 1990 Jun; 70(6):1518-24. PubMed ID: 1693371
[TBL] [Abstract][Full Text] [Related]
12. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
Izumi M; Larsen PR
J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211
[TBL] [Abstract][Full Text] [Related]
13. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
[TBL] [Abstract][Full Text] [Related]
14. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
[TBL] [Abstract][Full Text] [Related]
15. Treatment for childhood-onset Graves' disease in Japan: results of a nationwide questionnaire survey of pediatric endocrinologists and thyroidologists.
Sato H; Harada S; Yokoya S; Tanaka T; Asayama K; Mori M; Sasaki N
Thyroid; 2007 Jan; 17(1):67-72. PubMed ID: 17274753
[TBL] [Abstract][Full Text] [Related]
16. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
[TBL] [Abstract][Full Text] [Related]
17. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H
J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
[TBL] [Abstract][Full Text] [Related]
18. [Hyperthyroidism in childhood].
Lombardo G; De Luca F; Trimarchi F; Bianchi C
Pediatr Med Chir; 1983; 5(6):485-92. PubMed ID: 6085155
[TBL] [Abstract][Full Text] [Related]
19. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
20. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
Kahaly GJ; Grebe SK; Lupo MA; McDonald N; Sipos JA
Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
